Gagnon Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Gagnon Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-249,082	Closed	-$1.14M	–	32
2019 Q4	$1.14M	Hold	249,082	–	–	0.64%	30
2019 Q3	$1.52M	Hold	249,082	–	–	0.94%	30
2019 Q2	$1.52M	Hold	249,082	–	–	0.87%	30
2019 Q1	$1.38M	Hold	249,082	–	–	0.79%	29
2018 Q4	$1.41M	Buy	249,082 +54,503	+28%	+$402K	0.99%	27
2018 Q3	$2.04M	Hold	194,579	–	–	1.22%	25
2018 Q2	$2.16M	Buy	194,579 +65,006	+50%	+$585K	1.37%	24
2018 Q1	$1.04M	Buy	+129,573	New	+$1.04M	0.77%	28

Other funds holding CEMI

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Gagnon Advisors's CEMI Position: Q1 2020 in Review

Gagnon Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2020, closing a stake of 249,082 shares — an estimated $1.14M sold.

Gagnon Advisors first reported a position in CEMI in Q1 2018 and held it in 8 quarters. The position peaked at $2.16M in Q2 2018. 42 funds tracked by Wall St. Rank hold CEMI as of Q1 2020.

Gagnon Advisors reported no remaining Chembio diagnostics, Inc. position as of Q1 2020 after selling out during the quarter.
Gagnon Advisors sold 249,082 Chembio diagnostics, Inc. shares in Q1 2020, an estimated $1.14M.
Gagnon Advisors first reported a position in Chembio diagnostics, Inc. in Q1 2018 and held it in 8 quarters.
Gagnon Advisors's Chembio diagnostics, Inc. position peaked at $2.16M in Q2 2018.
42 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2020.

Based on Gagnon Advisors's 13F filing for Q1 2020, filed 11 May 2020.